Equity Overview
Price & Market Data
Price: $0.703
Daily Change: -$0.0554 / 7.88%
Daily Range: $0.666 - $0.798
Market Cap: $6,680,949
Daily Volume: 275,327
Performance Metrics
1 Week: -10.07%
1 Month: -17.05%
3 Months: -29.10%
6 Months: -56.37%
1 Year: -84.54%
YTD: -32.96%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country:
Details
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.